TREM2 as a central immunometabolic hub in Alzheimer’s disease: linking microglial states, lipid stress, and disease-stage-specific intervention
Guang Yang, Xiao Xu, Ying Xu · 2026
Read TREM2 as a central immunometabolic hub in Alzheimer’s disease: linking microglial states, lipid stress, and disease-stage-specific intervention by Guang Yang, Xiao Xu, Ying Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13473830.txt.
Description
Yang and colleagues reviewed in 2026 the biology of TREM2, a receptor on microglia, the brain's resident immune cells, in Alzheimer's disease. Rare variants in the TREM2 gene raise risk of late-onset Alzheimer's. The receptor senses lipids and damage signals, including myelin debris and aggregated amyloid, and switches microglia into disease-fighting states. The review covers signalling, state changes, lipid handling, and treatment ideas.
Through partner proteins, TREM2 activates pathways that reset microglia metabolism and gene activity. These shifts shape how plaques compact and how tau spreads. The soluble form of the receptor, shed into fluids, may serve as a disease marker. Treatments discussed include antibodies that boost receptor activity and drugs that modulate its shedding. They argue TREM2 sits at a control point where immunity, lipid metabolism, and degeneration meet.
Catalog record
| CREATOR | Guang Yang, Xiao Xu, Ying Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |